Quantcast

Latest HspE7 Stories

2010-02-18 03:00:00

MONTE CARLO, Monaco, Feb. 18 /PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the...

2009-10-15 14:20:10

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. The study, conducted by University of Illinois at Chicago and University of Chicago researchers, appears online and in the November issue of the Journal of Adolescent Health. The findings are reassuring in that girls and young women...

2009-10-05 09:30:03

It is estimated that more than 7,000 people are diagnosed with head and neck cancer each year in the UK and approximately 3,500 cases result in death. These cancers include tumors of the mouth, lips, throat and voice-box, and some have been linked to the sexually transmitted infection, HPV-16. Scientists at Liverpool analyzed the DNA of more than 90 cancerous tissue samples to look for genes that indicated infection. The team found that nearly two thirds of tonsil tumor samples showed...

2009-07-09 14:44:56

Northeastern University scientists in Boston say they have developed an early-stage, highly accurate cancer-screening technology. Professor Max Diem, who developed the the procedure, said it can determine within seconds whether a cell is cancerous, precancerous or normal. The scientists said the technology, for which there is a patent pending, automatically captures a fingerprint of the cell's biochemical composition, which is then analyzed by a computer for abnormalities. The technique can...

27fdacf7cef9734d090fa2c825da2d551
2009-07-09 11:40:00

The World Health Organization (WHO) has now approved a new cervical cancer vaccine from pharmaceutical company GlaxoSmithKline (GSK), which means that U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries worldwide. GSK stated Thursday that the approval would help expedite the accessibility of Cervarix globally. Gardasil, the rival vaccine made by pharmaceutical company Merck & Co., was the first cervical cancer vaccine to be approved by...

2009-02-09 09:30:00

MEMPHIS, Tenn., Feb. 9 /PRNewswire/ -- Through a new advertising campaign being launched in Memphis today, local women will soon learn more about cervical cancer screening and prevention. Cervical cancer is caused by high-risk types of the human papillomavirus (HPV) and QIAGEN, the maker of the only FDA-approved HPV test, has selected Memphis as a priority market for a new campaign to air its 30-second ad for the digene HPV Test on local TV stations starting today through April 20. QIAGEN...

2008-11-13 18:00:24

BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc. , a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the results of the Cervista HPV high-risk pivotal clinical trial. The Cervista HPV high-risk test is currently under review by the FDA in the U.S. and is expected to be launched in the European Union (EU) early in 2009. The clinical and...

2008-10-08 18:00:34

SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs. The company also announced that it will initiate a corporate restructuring that will extend the company's financial resources to pursue near-term corporate development opportunities, sale of specific programs, M&A and alternative financial...

2008-09-26 09:00:40

Guided Therapeutics, a medical technology company, has completed its FDA pivotal clinical trial for its LightTouch non-invasive cervical cancer detection device. The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue, the company said. Since the pivotal trial began, approximately 1,900 women have been tested to demonstrate the...

2008-09-25 09:00:54

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced completion of its U.S. Food and Drug Administration (FDA) pivotal clinical trial for its LightTouch(TM) non-invasive cervical cancer detection device. The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue. Since the pivotal trial began, approximately 1,900 women have...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related